Profile
Derrick Freitag served as the Chief Scientific Officer at Isotechnika, Inc. and Isotechnika Pharma, Inc. from 1996 to 2013.
He also held the same position at Aurinia Pharmaceuticals, Inc. Dr. Freitag earned a doctorate degree from the University of Alberta in 1994.
Former positions of Derrick Freitag
| Companies | Position | End |
|---|---|---|
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Chief Tech/Sci/R&D Officer | 2013-10-31 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Chief Tech/Sci/R&D Officer | 2013-10-22 |
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Derrick Freitag
| University of Alberta | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Health Technology |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
- Stock Market
- Insiders
- Derrick Freitag